Company intelligence / Profile preview
Neurologix
Fort Lee, New Jersey, United Statesneurologix.net ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Neurologix completed all surgical procedures in a clinical trial targeting advanced Parkinson’s disease using gene therapy. The company was among the early pioneers developing gene transfer therapies for serious brain and CNS disorders. No recent clinical results are available due to the company being out of business since the early 2010s.
- Therapeutic areas
- Neurology
- Modalities
- Gene therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major pharmaceutical or biotech partnerships reported in public sources.
Beyond the preview
Go deeper on Neurologix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neurologix.